Testing a Choline Diet in Neuroligin-Deficient C. elegans to Reduce Repetitive Behavior in Autism
DOI:
https://doi.org/10.47611/jsrhs.v11i3.2846Keywords:
Keywords: Autism Spectrum Disorder, C. elegans, neuroligin, repetitive behavior, acetylcholine, cholineAbstract
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by obsessive adherence to repetitive motion and behavior. Previously my research tested whether neuroligin, a brain molecule and potential determinant of behavioral traits in autism, could be used in neuroligin-deficient C.elegans (strain NLG-1) to model autism. The experiment studied the sensitivity of neuroligin-deficient C. elegan to sensory stimuli, a core symptom of autism, and the results led to the conclusion that NLG-1 C. elegans could be used as a potential model for autism in worms. This project is a continuation study from last year that tested whether choline supplementation reduced repetitive locomotion in neuroligin-deficient C. elegans. Since people with neurological disorders are often deficient in the neurotransmitter acetylcholine, it was hypothesized that increasing the amount of choline, a building block of acetylcholine, would reduce repetitive behaviors. The C. elegans were age-synched to test three different age groups of worms, and over a 1-minute period, and the repetitive movement of the worms exposed to choline was compared to worms without choline using microscope camera software. The results showed the addition of choline in the diet significantly reduced the amount of repetitive locomotion in NLG-1 C. elegans in all 3 age groups. This study suggests that for people with ASD, adding choline to the diet in their daily schedule may help them reduce repetitive behavior. On a larger scale, scientists can use NLG-1 C. elegans to target neurochemical systems to develop early treatments, and ultimately reduce the significant deficits of autism.
Downloads
References or Bibliography
Agam, G., Taylor, Z., Vainer, E., & Golan, H. M. (2020). The influence of choline treatment on behavioral and neurochemical autistic-like phenotype in mthfr-deficient mice. Translational Psychiatry, 10(1). https://doi.org/10.1038/s41398-020-01002-1
Ahmed, N. Y., Knowles, R., & Dehorter, N. (2019). New insights into cholinergic neuron diversity. Frontiers in Molecular Neuroscience, 12. https://doi.org/10.3389/fnmol.2019.00204
American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: 2000.
Amodeo, D. A., Yi, J., Sweeney, J. A., & Ragozzino, M. E. (2014). Oxotremorine treatment reduces repetitive behaviors in BTBR t+ tf/J mice. Frontiers in Synaptic Neuroscience, 6. https://doi.org/10.3389/fnsyn.2014.00017
Autism and Vaccines | Vaccine Safety | CDC. (2021, December 1). Centers for Disease Control and Prevention. Retrieved March 9, 2022, from https://www.cdc.gov/vaccinesafety/concerns/autism.html
Bang, M., Lee, S. H., Cho, S.-H., Yu, S.-A., Kim, K., Lu, H. Y., Chang, G. T., & Min, S. Y. (2017). Herbal medicine treatment for children with autism spectrum disorder: A systematic review. Evidence-Based Complementary and Alternative Medicine, 2017, 1-12. https://doi.org/10.1155/2017/8614680
Bellier, J.-P., & Kimura, H. (2007). Acetylcholine synthesis by choline acetyltransferase of a peripheral type as demonstrated in adult rat dorsal root ganglion. Journal of Neurochemistry, 101(6), 1607-1618. https://doi.org/10.1111/j.1471-4159.2007.04458.x
Bishop, S. L., Richler, J., Cain, A. C., & Lord, C. (2007). Predictors of perceived negative impact in mothers of children with autism spectrum disorder. American Journal on Mental Retardation, 112(6), 450. https://doi.org/10.1352/0895-8017(2007)112[450:POPNII]2.0.CO;2
Butterweck, V., Winterhoff, H., & Herkenham, M. (2001). St John's wort, hypericin, and imipramine: A comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats. Molecular Psychiatry, 6(5), 547-564. https://doi.org/10.1038/sj.mp.4000937
Damiano, C. R., Mazefsky, C. A., White, S. W., & Dichter, G. S. (2014). Future directions for research in autism spectrum disorders. Journal of Clinical Child & Adolescent Psychology, 43(5), 828-843. https://doi.org/10.1080%2F15374416.2014.945214
Dawson, G., Rogers, S., Munson, J., Smith, M., Winter, J., Greenson, J., Donaldson, A., & Varley, J. (2010). Randomized, controlled trial of an intervention for toddlers with autism: The early start Denver model. Pediatrics, 125(1), e17-e23. https://doi.org/10.1542/peds.2009-0958
Faras, H., Al ateeqi, N., & Tidmarsh, L. (2010). autism spectrum disorders. Annals of Saudi Medicine, 30(4), 295-300. https://doi.org/10.4103/0256-4947.65261
Hunter, P. (2008). The paradox of model organisms. EMBO Reports, 9(8), 717-720. https://doi.org/10.1038%2Fembor.2008.142
Karvat, G., & Kimchi, T. (2013). Acetylcholine elevation relieves cognitive rigidity and social deficiency in a mouse model of autism. Neuropsychopharmacology, 39(4), 831-840. https://doi.org/10.1038/npp.2013.274
Katz, M., Corson, F., Keil, W., Singhal, A., Bae, A., Lu, Y., Liang, Y., & Shaham, S. (2019). Glutamate spillover in C. elegans triggers repetitive behavior through presynaptic activation of mgl-2/mglur5. Nature Communications, 10(1). https://doi.org/10.1038/s41467-019-09581-4
King, B. H., Hollander, E., Sikich, L., Mccracken, J. T., Scahill, L., Bregman, J. D., Donnelly, C. L., Anagnostou, E., Dukes, K., Sullivan, L., Hirtz, D., Wagner, A., & Ritz, L. (2009). Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior. Archives of General Psychiatry, 66(6), 583. https://doi.org/10.1001/archgenpsychiatry.2009.30
Lam, K. S.l., Aman, M. G., & Arnold, L. E. (2006). Neurochemical correlates of autistic disorder: A review of the literature. Research in Developmental Disabilities, 27(3), 254-289. https://doi.org/10.1016/j.ridd.2005.03.003
Levy, S. E., & Hyman, S. L. (2008). Complementary and alternative medicine treatments for children with autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America, 17(4), 803-820. https://doi.org/10.1016/j.chc.2008.06.004
Lynch, R., Diggins, E. L., Connors, S. L., Zimmerman, A. W., Singh, K., Liu, H., Talalay, P., & Fahey, J. W. (2017). Sulforaphane from broccoli reduces symptoms of autism: A follow-up case series from a randomized double-blind study. Global Advances in Health and Medicine, 6, 2164957X1773582. https://doi.org/10.1177/2164957X17735826
Matthies, D. S., Fleming, P. A., Wilkes, D. M., & Blakely, R. D. (2006). The caenorhabditis elegans choline transporter cho-1 sustains acetylcholine synthesis and motor function in an activity-dependent manner. Journal of Neuroscience, 26(23), 6200-6212. https://doi.org/10.1523/JNEUROSCI.5036-05.2006
Mcdermott, C. R., Farmer, C., Gotham, K. O., & Bal, V. H. (2020). Measurement of subcategories of repetitive behaviors in autistic adolescents and adults. autism in Adulthood, 2(1), 48-60. https://doi.org/10.1089/aut.2019.0056
Nadeau, J., Sulkowski, M. L., Ung, D., Wood, J. J., Lewin, A. B., Murphy, T. K., May, J. E., & Storch, E. A. (2011). Treatment of comorbid anxiety and autism spectrum disorders. Neuropsychiatry, 1(6), 567-578. https://doi.org/10.2217/npy.11.62
Neuroligin dependence of social behavior in Caenorhabditis elegans provides a model to investigate an autism-associated gene. (n.d.). https://doi.org/10.1093/hmg/ddaa232
Orenbuch, A., Fortis, K., Taesuwan, S., Yaffe, R., Caudill, M. A., & Golan, H. M. (2019). Prenatal nutritional intervention reduces autistic-like behavior rates among mthfr-deficient mice. Frontiers in Neuroscience, 13. https://doi.org/10.3389/fnins.2019.00383
Picciotto, M., Higley, M., & Mineur, Y. (2012). Acetylcholine as a neuromodulator: Cholinergic signaling shapes nervous system function and behavior. Neuron, 76(1), 116-129. https://doi.org/10.1016/j.neuron.2012.08.036
Rawsthorne, H., Calahorro, F., Feist, E., Holden-dye, L., O'connor, V., & Dillon, J. (2020). Neuroligin dependence of social behavior in caenorhabditis elegans provides a model to investigate an autism-associated gene. Human Molecular Genetics, 29(21), 3546-3553. https://doi.org/10.1093/hmg/ddaa232
Rojas, D. C. (2014). The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment. Journal of Neural Transmission, 121(8), 891-905. https://doi.org/10.1007/s00702-014-1216-0
Soorya, L., Kiarashi, J., & Hollander, E. (2008). Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America, 17(4), 753-771. https://doi.org/10.1016/j.chc.2008.06.003
Stigler, K. A., & Mcdougle, C. J. (2008). Pharmacotherapy of irritability in pervasive developmental disorders. Child and Adolescent Psychiatric Clinics of North America, 17(4), 739-752. https://doi.org/10.1016/j.chc.2008.06.002
Tata, A., Velluto, L., D'angelo, C., & Reale, M. (2014). Cholinergic system dysfunction and neurodegenerative diseases: Cause or effect? CNS & Neurological Disorders - Drug Targets, 13(7), 1294-1303. https://doi.org/10.2174/1871527313666140917121132
Volkmar, F. R., & Wolf, J. M. (2013). When children with autism become adults. World Psychiatry, 12(1), 79-80. https://doi.org/10.1002/wps.20020
Published
How to Cite
Issue
Section
Copyright (c) 2022 Sasha Balasingam; Cathy Messenger
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
